Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results save search
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
Published: 2024-03-05 (Crawled : 15:00) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: 4427.49%
H: 0.0%
C: -11.13%
business update therapeutics financial results
TransCode Therapeutics Announces Positive Results in Non-human Primates with its Lead Therapeutic Candidate, TTX-MC138
Published: 2023-07-31 (Crawled : 11:00) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 3986.21%
H: 1.43%
C: -7.17%
mc138 ttx-mc138 positive therapeutics results
Katapult to Announce Second Quarter 2023 Financial Results on August 9, 2023
Published: 2023-07-26 (Crawled : 20:00) - globenewswire.com
KPLT | $9.07 4.01% 3.86% 6.6K
|
Real Estate and Rental and Leas...
|
| O: 2368.75%
H: 5.01%
C: -3.8%
financial results
Neovasc to Report First Quarter Financial Results on May 12, 2022
Published: 2022-04-29 (Crawled : 13:20) - globenewswire.com
NVCN | $30.03 1.66% -2.02% 0
|
Health Technology
|
| O: 2289.74%
H: 0.0%
C: 0.0%
report results
Avinger to Announce Full-Year 2021 Results on March 22
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
AVGR | $4.02 2.55% 2.49% 5.6K
|
Health Technology
|
| O: 1724.4%
H: 0.0%
C: 0.0%
results
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1599.62%
H: 4.16%
C: -5.48%
results
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 11:00) - globenewswire.com
SYBX | $1.815 -0.82% -0.83% 54K
|
Health Technology
|
| O: 1406.8%
H: 1.37%
C: 0.87%
business update financial results
Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
Published: 2023-08-07 (Crawled : 14:00) - biospace.com/
VTGN | $4.77 1.49% 1.47% 150K
|
Health Technology
|
| O: 1090.48%
H: 0.0%
C: 0.0%
ph94 positive spray trial results
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 895.97%
H: 14.34%
C: 11.7%
business year update pharmaceuticals financial results
Novan Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-11 (Crawled : 23:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 895.67%
H: 5.22%
C: -3.48%
financial results results
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
Published: 2023-09-28 (Crawled : 10:00) - globenewswire.com
BNOX | $0.98 -1.17% 14K
|
n/a
|
| O: 480.71%
H: 12.06%
C: -41.08%
bnc210 positive topline trial results
Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
SLNO | News | $37.53 1.02% 1.01% 190K
|
Health Technology
|
| O: 374.04%
H: 44.29%
C: 27.62%
positive therapeutics results study
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results
Published: 2023-06-06 (Crawled : 10:00) - intellipharmaceutics.com
IPCIF | $0.07 -29.49% 4.2K
|
Health Technology
|
| O: 350.0%
H: 0.0%
C: 0.0%
year results
Madrigal Announces Positive Topline Results from the Pivotal Phase 3 MAESTRO-NASH Clinical Trial of Resmetirom for the Treatment of NASH and Liver Fibrosis
Published: 2022-12-19 (Crawled : 13:00) - biospace.com/
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: 219.37%
H: 0.0%
C: 0.0%
treatment fibrosis liver topline trial positive nash
Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th
Published: 2022-12-18 (Crawled : 00:00) - globenewswire.com
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: 219.37%
H: 0.0%
C: 0.0%
pharmaceuticals topline results study
Clubhouse Media Group, Inc. Reports 2023 Financial Results, Highlighting Increased Revenue and Decreased Expenses
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
CMGR | $0.0003 -50.0% 14M
|
Health Care and Social Assistan...
|
| O: 200.0%
H: 0.0%
C: -33.33%
media revenue financial
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
Published: 2024-02-26 (Crawled : 14:30) - biospace.com/
AKLI | $0.239 2.93% 2.85% 50K
|
|
| O: 193.1%
H: 13.69%
C: -30.36%
endeavorrx japan positive adhd trial results
BeyondSpring Announces Positive Topline Results from its DUBLIN-3 Registrational Trial of Plinabulin in Combination with Docetaxel for the Treatment of 2nd/3rd Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Wild Type
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: 191.8%
H: 6.76%
C: -5.41%
treatment lung cancer positive results cancer topline trial plinabulin
Avricore Health Corporate Updates on Audited Results for 2022
Published: 2023-05-02 (Crawled : 12:00) - globenewswire.com
AVCRF | $0.069 207.83% 18K
|
Health Technology
|
| O: 182.54%
H: 0.0%
C: 0.0%
health results
Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb
Published: 2022-12-07 (Crawled : 12:20) - globenewswire.com
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 181.13%
H: 0.0%
C: 0.0%
pra023 enabling positive phase 2b
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.